These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8065777

  • 1. New therapeutic agents marketed in 1993.
    Hussar DA.
    Pa Med; 1994 Jun; 97(6):22-3. PubMed ID: 8065777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New therapeutic agents marketed in 1993.
    Hussar DA.
    Pa Med; 1994 May; 97(5):12-7. PubMed ID: 8036027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New therapeutic agents marketed in 1995.
    Hussar DA.
    Pa Med; 1996 Apr; 99(4):43-6. PubMed ID: 8935886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009.
    Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL.
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):772-7. PubMed ID: 21574210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnostic kits in parasitology: which controls?].
    Rossi P.
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences.
    Lexchin J.
    Health Policy; 2006 Dec; 79(2-3):214-20. PubMed ID: 16472888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Canadian and US drug approval times and safety considerations.
    Rawson NS, Kaitin KI.
    Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
    [Abstract] [Full Text] [Related]

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. How are drugs approved? Part 3. The stages of drug development.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2008 Mar; 46(3):17-20. PubMed ID: 18416270
    [Abstract] [Full Text] [Related]

  • 19. Drugs and other product choices.
    Hyman PM, Carvajal R.
    Dermatol Ther; 2009 Mar; 22(3):216-24. PubMed ID: 19453345
    [Abstract] [Full Text] [Related]

  • 20. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Mar; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.